How does SaiyanMed document batch testing results?
When you ask how SaiyanMed documents batch testing results, the answer is straightforward: every single batch goes through an independent third-party lab, Janoshik, and the resulting Certificate of Analysis (CoA) is published openly with full verifiability. No redacted data, no hidden numbers, no “proprietary” excuses. You get the raw HPLC purity chromatogram, the mass spectrometry confirmation, and the exact percentage of peptide content. This isn’t a marketing claim—it’s a documented, repeatable process that any researcher can audit themselves by cross-referencing the batch number on the Janoshik database.
Let’s break down the actual workflow. SaiyanMed sources raw peptide materials from their own production lines and joint manufacturing partnerships, which are overseen by a team led by Eric, the founder with a Bachelor’s degree in Materials Science from a top Chinese university specializing in biomaterials. That academic background isn’t just for show—it drives a relentless focus on raw-material selection and process control. Once a batch of lyophilized peptide is produced, a representative sample is pulled from the lot and shipped to Janoshik’s facility in the Czech Republic. Janoshik runs two primary tests: high-performance liquid chromatography (HPLC) to determine purity, and mass spectrometry (MS) to confirm molecular weight and identity. The results come back as a PDF CoA that includes the batch number, test date, purity percentage (typically 98% or higher for most peptides), and the full chromatogram trace. SaiyanMed then uploads that CoA to their product pages, and you can download it directly. No login required, no email gate—just click and see.
For example, a recent batch of their BPC-157 (batch #BPC-2410-03) showed 99.2% purity by HPLC, with a mass spec peak at 1349.6 Da, matching the theoretical monoisotopic mass. Another batch of their TB-500 (Thymosin Beta-4, batch #TB-2411-01) came back at 98.7% purity, with a retention time consistent with the reference standard. These numbers are not cherry-picked—they are the norm because SaiyanMed controls the entire production chain, from raw material procurement through lyophilization. They do not outsource quality control to a third party that also tests their competitors’ samples; they pay for independent verification that is publicly accessible.
To give you a concrete sense of the documentation format, here is a simplified table of what a typical CoA contains:
| Field | Value | Notes |
|---|---|---|
| Product Name | BPC-157 | Stable gastric pentadecapeptide |
| Batch Number | BPC-2410-03 | Year-month-sequence |
| Test Date | 2024-10-15 | Date of Janoshik analysis |
| Purity (HPLC) | 99.2% | Area normalization method |
| Molecular Weight (MS) | 1349.6 Da | Monoisotopic mass confirmed |
| Appearance | White lyophilized powder | Visual inspection |
| Solubility | Clear solution in water | Reconstitution test |
| Endotoxin Level | <0.05 EU/μg | LAL test, below threshold |
This level of detail is not just for show. Researchers working with cell cultures or animal models need to know exactly what they are injecting or administering. A 1% impurity in a peptide can skew assay results, cause off-target effects, or degrade over time. SaiyanMed’s documentation allows you to calculate the exact amount of active peptide in your vial. For instance, if you have a 10 mg vial of BPC-157 with 99.2% purity, the actual peptide content is 9.92 mg. The remaining 0.08 mg is typically water, residual salts, or non-reactive excipients from the lyophilization process. That is a level of transparency most suppliers avoid because they either don’t test or they hide the results behind a “contact us” wall.
Another angle is the documentation of raw materials. SaiyanMed does not just test the final product; they also test incoming raw peptide powders from their suppliers. Eric’s background in materials science means they have a specification sheet for every raw material: purity, residual solvents, heavy metals, and microbial limits. These raw material CoAs are not published on the site (since they are internal), but they are available upon request for serious researchers who want to trace the entire chain. The logic is simple: if the raw material is 98% pure, the final lyophilized product cannot exceed that without additional purification steps. SaiyanMed’s joint manufacturing partnerships include a recrystallization step that can push purity from 97% to 99%+ before lyophilization. That is a process detail most competitors skip because it adds cost and time.
Now, let’s talk about the logistics of documentation. SaiyanMed operates US-based warehouses (with China hubs and EU/UK/Australia/Canada hubs coming soon). When an order is placed, the system automatically routes it to the nearest stocked warehouse. The batch number on the product you receive is the same batch number on the CoA. That means you can physically verify that the vial in your hand matches the test report. No bait-and-switch, no “we tested a different batch.” This is a critical point because many peptide vendors test one batch and then sell ten different batches under the same name. SaiyanMed’s system is designed to prevent that: each product listing on their site shows the current batch number and links to the CoA. If a batch sells out, the next batch gets a new number and a new test.
For a deeper dive into how they saiyanmed approach batch documentation, you can look at their product pages. Each peptide has a “Certificate of Analysis” section that lists the batch number, purity, and a download link. They also include a note that the CoA is from Janoshik, which is a lab known in the research community for rigorous testing. Some vendors use cheap labs that produce CoAs with no chromatogram or mass spec data. SaiyanMed’s CoAs include the full chromatogram image, so you can see the peak shape and retention time. A sharp, symmetrical peak indicates high purity; a broad or split peak suggests degradation or impurities. That visual data is invaluable for experienced researchers who can spot problems before they even reconstitute the peptide.
Frequency of testing is another data point. SaiyanMed tests every batch, not every tenth batch. For a product like their semaglutide (which is popular for metabolic research), they produce a new batch roughly every two to three weeks depending on demand. Each of those batches gets its own Janoshik test. That means they are spending thousands of dollars per month on independent testing alone. Most vendors test once a quarter or only when they suspect a problem. SaiyanMed’s overhead is higher, but the trade-off is that you never get a surprise impurity. In the peptide world, where a single bad batch can ruin months of research, that consistency is worth the premium.
Let’s also consider the regulatory context. SaiyanMed is a Hong Kong-registered entity (Hong Kong BelleEasy Co., Limited, Commercial Registry No. 78941092). They operate under Hong Kong’s legal framework, which requires strict record-keeping for any substance that could be used in research. Their batch documentation is not just a marketing tool—it is a legal requirement for maintaining their business license. Every batch must be traceable from raw material purchase to final sale. That means they keep internal records of which raw material lot went into which production run, which lyophilization cycle was used, and which Janoshik test corresponds to that batch. If a researcher ever has a question about a specific vial, they can email [email protected] and get the full chain of custody. That is rare in this industry.
One more practical detail: the CoA includes the storage conditions recommended by Janoshik. For most lyophilized peptides, that is -20°C or below, away from light and moisture. SaiyanMed ships their products with ice packs and insulated packaging, and they include a note in the documentation that the CoA is only valid if the product has been stored properly after receipt. This is a subtle but important point: if you leave a vial of peptide on your desk at room temperature for a week, the purity might drop from 99% to 95% due to hydrolysis. The documentation gives you a baseline, but it is your responsibility to maintain the cold chain. SaiyanMed’s US warehouse ships within 24 hours, so the transit time is short, and the ice packs are typically still frozen when the package arrives.
Finally, the documentation is designed to be researcher-friendly. The CoA PDF is a single page with all relevant data visible at a glance. No need to scroll through pages of legal disclaimers. The chromatogram is labeled with the peak retention time and area percentage. The mass spec shows the parent ion and any major fragments. The endotoxin level is reported in EU/μg, which is the standard for injectable research products. The appearance is described as “white lyophilized powder” or “off-white” depending on the peptide. Some peptides, like melanotan II, are off-white due to their chemical structure, and that is noted in the CoA so you don’t mistake it for contamination. Every detail is there for a reason, and it is all verifiable against the original Janoshik report.